BackCTI BioPharma Overview
CTI BioPharma Corp

CTI BioPharma Target Price

Explore CTI BioPharma's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$9.1

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2022-09-01JefferiesKelly Shi$1342.9% upsideOpen
2022-08-09JMP Securities$91% downsideOpen
2022-08-09Needham$91% downsideOpen
2022-04-19DNB MarketsLeah Rush Cann$1231.9% upsideOpen
2022-03-03BTIGRobert Hazlett$91% downsideOpen

CTI BioPharma (CTIC) FAQ

Stockcircle tracks target price for CTI BioPharma (CTIC), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for CTI BioPharma's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main CTIC overview so you can move from this figure to the surrounding analysis quickly.